These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1366997)

  • 21. Water soluble derivatives of rebeccamycin.
    Kaneko T; Wong H; Utzig J; Schurig J; Doyle T
    J Antibiot (Tokyo); 1990 Jan; 43(1):125-7. PubMed ID: 2307626
    [No Abstract]   [Full Text] [Related]  

  • 22. Syntheses and antiproliferative activities of rebeccamycin analogues bearing two 7-azaindole moieties.
    Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Renard P; Prudhomme M
    Bioorg Med Chem; 2003 Mar; 11(5):679-87. PubMed ID: 12537997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biosynthesis of indolocarbazoles in a heterologous E. coli host.
    Hyun CG; Bililign T; Liao J; Thorson JS
    Chembiochem; 2003 Jan; 4(1):114-7. PubMed ID: 12512086
    [No Abstract]   [Full Text] [Related]  

  • 24. [Scientific methodological bases in the search for producers of new antibiotics].
    Solov'eva NK
    Antibiot Khimioter; 1988 Aug; 33(8):630-6. PubMed ID: 3058067
    [No Abstract]   [Full Text] [Related]  

  • 25. Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition.
    Bailly C; Qu X; Graves DE; Prudhomme M; Chaires JB
    Chem Biol; 1999 May; 6(5):277-86. PubMed ID: 10322124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new variety of Actinoplanes-producing sibiromycin].
    Hu JL; Xie MY; Lu WY
    Wei Sheng Wu Xue Bao; 1986 Mar; 26(1):90-3. PubMed ID: 3604209
    [No Abstract]   [Full Text] [Related]  

  • 27. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic generation of the chromopyrrolic acid scaffold of rebeccamycin by the tandem action of RebO and RebD.
    Howard-Jones AR; Walsh CT
    Biochemistry; 2005 Dec; 44(48):15652-63. PubMed ID: 16313168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimers from dechlorinated rebeccamycin: synthesis, interaction with DNA, and antiproliferative activities.
    Marminon C; Facompré M; Bailly C; Hickman J; Pierré A; Pfeiffer B; Renard P; Prudhomme M
    Eur J Med Chem; 2002 May; 37(5):435-40. PubMed ID: 12008058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of mutants blocked in calicheamicin biosynthesis.
    Rothstein DM; Love SF
    J Bacteriol; 1991 Dec; 173(23):7716-8. PubMed ID: 1938969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
    Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
    Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
    Long BH; Rose WC; Vyas DM; Matson JA; Forenza S
    Curr Med Chem Anticancer Agents; 2002 Mar; 2(2):255-66. PubMed ID: 12678746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments of rebeccamycin analogues as topoisomerase I inhibitors and antitumor agents.
    Prudhomme M
    Curr Med Chem; 2000 Dec; 7(12):1189-212. PubMed ID: 11032967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1999 Feb; 42(4):584-92. PubMed ID: 10052965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicities of three rebeccamycin derivatives in the National Cancer Institute screening of 60 human tumor cell lines.
    Moreau P; Holbeck S; Prudhomme M; Sausville EA
    Anticancer Drugs; 2005 Feb; 16(2):145-50. PubMed ID: 15655411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.
    Bailly C; Carrasco C; Hamy F; Vezin H; Prudhomme M; Saleem A; Rubin E
    Biochemistry; 1999 Jul; 38(27):8605-11. PubMed ID: 10393535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic sibiromycin by Streptosporangium sibiricum.
    Hurley LH; Lasswell WL; Malhotra RK; Das NV
    Biochemistry; 1979 Sep; 18(19):4225-9. PubMed ID: 582800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin.
    Anizon F; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T; Aubertin AM
    Bioorg Med Chem; 1998 Sep; 6(9):1597-604. PubMed ID: 9801830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of the enediyne antitumor antibiotic C-1027.
    Liu W; Christenson SD; Standage S; Shen B
    Science; 2002 Aug; 297(5584):1170-3. PubMed ID: 12183628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational biosynthesis of new antibiotics.
    Daum SJ; Lemke JR
    Annu Rev Microbiol; 1979; 33():241-65. PubMed ID: 386923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.